Skip to main content

Topic

Pharmaceuticals

1,010 published works

  1. Drug & Device Law

    Running the Table – The Ten Best Prescription Drug/Medical Device Decisions of 2025

    By Bexis

    A year ago, Bexis thought this would be the last blogpost he would ever write, and that he would retire along with 2025.  Not gonna happen – at least not…

  2. Substance Law Blog

    Drug Identification Numbers (DINs) in Canada

    By Publisher

    What is a Drug Identification Number (DIN)? The Purpose of a DIN A Drug Identification Number, or DIN, is a unique eight-digit code assigned by Health Canada to drug products…

  3. GoodLifeSci

    EU Pharma Package: Sharp New Tools With Limited Protections

    By Maarten Meulenbelt, Josefine Sommer, Anne Robert, Dr. Chris Boyle, Alix Vermulst

    Last week, concluding a seven-year process, the Council of the European Union and the European Parliament agreed on the EU Pharma Package consisting of a new Pharmaceutical Directive and Pharmaceutical…

  4. Pro Te: Solutio

    Memento Michigan Compiled Law § 600.2946(5): An Homage to Michigan’s Former Drug Immunity Law

    By Butler Snow

    In 1995, the Michigan Legislature enacted its Drug Immunity Law, which provided an absolute defense for pharmaceutical companies in product liability suits stemming from the safety and efficacy of their…

  5. As Prescribed

    Agreement Reached on EU Pharma Package, but Questions Remain

    By Morgan Lewis

    Two and a half years after the initial proposal, agreement has been reached by the EU institutions on the so-called EU Pharma Package. The Package represents a comprehensive overhaul of…

  6. Inside EU Life Sciences

    EU Announces Political Agreement on Pharma Law Review

    By Grant Castle, Peter Bogaert, Robin Blaney, Marie Doyle-Rossi, Spiros Drosos, Anna Wawrzyniak

    At just after 5 am on 11 December 2025, the EU Parliament and the Council reached agreement on a new directive and a new regulation that will result in a…

  7. BioSlice Blog

    European institutions agree on the reform to the EU Regulatory Framework for Medicinal Products

    By Alexander Roussanov, Libby Amos-Stone, Christopher Bates, Ana Gonzalez-Lamuno

    On 11 December, after overnight interinstitutional negotiations between the European Parliament and the Council of the European Union (“Council”) and the European Commission, the institutions reached a provisional political agreement…

  8. Big Molecule Watch

    FDA Approves Lupin’s Pegfilgrastim Biosimilar, ARMLUPEG

    By Timothy Beavers

    Lupin Limited announced on December 1 that it received FDA approval for its biosimilar product, ARMLUPEG (pegfilgrastim-unne).  ARMLUPEG is approved as a 6 mg/0.6 mL single-dose prefilled syringe presentation, referencing…

  9. Global Policy Watch

    Landmark UK-US Pharmaceutical Deal

    By Grant Castle, Raj Gathani, Dan Spivey

    On 1 December 2025, the UK Government announced a “landmark” UK-US pharmaceutical deal.   Under the deal, the UK claims to be (so far) the only country to secure zero-percent tariffs…

  10. Pharmacy & Healthcare Legal Blog

    Navigating 2026 Part D pharmacy reimbursements. Resources.

    By Natalia Mazina

    Starting January 1, 2026, pharmacies will be reimbursed under a different model for dispensing certain Part D Medicare drugs. These changes are a part of the implementation of the Inflation…